FDA to test all heparin at U.S. border

Mar 16, 2008

The U.S. Food and Drug Administration has issued an import alert and plans to test all shipments of the drug heparin before they enter the country.

Multiple batches of heparin sold by Baxter International have been been found to contain a mysterious contaminant, The Wall Street Journal reported Friday. The contaminated product was made in a Chinese plant.

Baxter told the newspaper company officials think the contaminant comes from pig intestines used to produce the popular anti-coagulant. The company said four recent deaths may have been at least partly related to reactions to its heparin.

Five manufacturers have agreed to test all shipments of heparin and its main ingredients for contamination, the newspaper said.

Copyright 2008 by United Press International

Explore further: US appeals court upholds delay in Alzheimer's drug swap

Related Stories

Heparin recall spreads in Europe

Mar 27, 2008

France, Italy and Denmark are recalling heparin after an Italian firm purchased contaminated ingredients from China, EU drug regulators said.

Recommended for you

US appeals court upholds delay in Alzheimer's drug swap

15 hours ago

A federal appeals court has rejected a drug manufacturer's appeal and affirmed a judge's order that Actavis PLC keep distributing its widely used Alzheimer's medication until after its patent expires this summer.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.